MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16935

  1. 924 Posts.
    lightbulb Created with Sketch. 158
    rofl what rot.

    History - 2 CRLS and as many Tyoe A meetings have said the FDA is having none of the MSBs proofs. Many in these dark forums seemed to have thought the FDA had agreed ... and did not read what the FDA said.

    MSB had a rolling BLA in which it made some representations of the likelihood of success that are now subject to class action in Australia.



    You make such bold statements without any proof.

    Why?

    Your holding must be hurting you at 0.36 - given the opportunity cost of the BBSW alone. That's of course if you do hold.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.